NDC 0002-6145

Baqsimi

Glucagon

Baqsimi is a Nasal Powder in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Glucagon.

• Product ID: 0002-6145_3928d4ab-2923-4932-91cb-d18870b0972e
• NDC: 0002-6145
• Product Type: Human Prescription Drug
• Proprietary Name: Baqsimi
• Generic Name: Glucagon
• Dosage Form: Powder
• Route of Administration: NASAL
• Marketing Start Date: 2019-07-24
• Marketing Category: NDA / NDA
• Application Number: NDA210134
• Labeler Name: Eli Lilly and Company
• Substance Name: GLUCAGON
• Active Ingredient Strength: 3 mg/1
• Pharm Classes: Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0002-6145-11

1 TUBE in 1 CARTON (0002-6145-11) > 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) > 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)

• Marketing Start Date: 2019-08-06
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0002-6145-27 [00002614527]

Baqsimi POWDER

• Marketing Category: NDA
• Application Number: NDA210134
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-08-06

NDC 0002-6145-11 [00002614511]

Baqsimi POWDER

• Marketing Category: NDA
• Application Number: NDA210134
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-08-06

NDC 0002-6145-02 [00002614502]

Baqsimi POWDER

• Marketing Category: NDA
• Application Number: NDA210134
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-08-09

NDC 0002-6145-01 [00002614501]

Baqsimi POWDER

• Marketing Category: NDA
• Application Number: NDA210134
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-07-31

Drug Details

Active Ingredients

Ingredient	Strength
GLUCAGON	3 mg/1

OpenFDA Data

• SPL SET ID: 3fdb4e92-2e19-487d-9f14-99871e9fd15a
• Manufacturer:
  • Eli Lilly and Company
• UNII:
  • 76LA80IG2G
• RxNorm Concept Unique ID - RxCUI:
  • 2180671
  • 2180666

Pharmacological Class

• Antihypoglycemic Agent [EPC]
• Gastrointestinal Motility Inhibitor [EPC]
• Increased Gluconeogenesis [PE]
• Increased Glycogenolysis [PE]
• Decreased GI Smooth Muscle Tone [PE]
• Decreased GI Motility [PE]
• Decreased Glycolysis [PE]

NDC Crossover Matching brand name "Baqsimi" or generic name "Glucagon"

NDC	Brand Name	Generic Name
0002-6145	Baqsimi	glucagon
0002-8031	Glucagon	glucagon
0548-5850	Glucagon	Glucagon
43742-0252	Glucagon	Glucagon
43742-0734	Glucagon	Glucagon
50090-0639	Glucagon	glucagon
51662-1498	GLUCAGON	GLUCAGON
63083-1555	Glucagon	Glucagon
63323-582	Glucagon	Glucagon
63323-593	Glucagon	Glucagon
63323-594	Glucagon	Glucagon
63323-596	Glucagon	Glucagon
64725-8031	Glucagon	glucagon